Minli Chen
Overview
Explore the profile of Minli Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai Z, Deng L, Fan Y, Ren Y, Ling Y, Tu J, et al.
Antioxidants (Basel)
. 2024 Jan;
13(1).
PMID: 38275624
The miniature pig is a suitable animal model for investigating human cardiovascular diseases. Nevertheless, the alterations in lipid metabolism within atherosclerotic plaques of miniature pigs, along with the underlying mechanisms,...
2.
Wang X, Shu X, Su X, Xiong Y, Xiong Y, Chen M, et al.
Genes (Basel)
. 2023 Oct;
14(10).
PMID: 37895223
As a C4 warm-season turfgrass, centipedegrass ( (Munro) Hack.) is known for its exceptional resilience to intensive maintenance practices. In this research, the most stably expressed reference genes in the...
3.
Shen L, Wang J, Pan Y, Huang J, Zhu K, Tu H, et al.
Nutrients
. 2023 Oct;
15(20).
PMID: 37892500
Background: Atherosclerosis (AS) is a chronic progressive disease caused by lipometabolic disorder. However, the pathological characteristics and mechanism of AS have not been fully clarified. Through high-fat and high-cholesterol diet...
4.
Li Y, Chen J, Tu H, Ma Q, Wang M, Chen J, et al.
BMC Complement Med Ther
. 2023 Oct;
23(1):385.
PMID: 37891536
Background: Diabetic encephalopathy (DE) is a complication of diabetes that leads to cognitive and behavioral decline. Utilizing safe and effective complementary and alternative medications for its management is a wise...
5.
Yang Q, Xu Y, Shen L, Pan Y, Huang J, Ma Q, et al.
J Immunol Res
. 2022 Aug;
2022:7128230.
PMID: 35935588
Coronary atherosclerosis (CA) is a chronic and evolving inflammatory disease characterized by the build-up of atherosclerotic plaque in the wall of coronary arteries. Guanxinning tablet (GXNT) is a novel Chinese...
6.
Ling Y, Shi J, Ma Q, Yang Q, Rong Y, He J, et al.
Front Pharmacol
. 2021 Dec;
12:754527.
PMID: 34925014
Vasodilatory therapy plays an important role in the treatment of cardiovascular diseases, especially hypertension and coronary heart disease. Previous research found that Guanxinning tablet (GXNT), a traditional Chinese compound preparation...
7.
Zhang F, Xu Y, Shen L, Huang J, Xu S, Li J, et al.
Evid Based Complement Alternat Med
. 2021 Nov;
2021:9253281.
PMID: 34745305
Based on accumulating evidence, Alzheimer's disease (AD) is related to hypercholesterolemia, gut microbiota, and host metabolites. GuanXinNing Tablet (GXN) is an oral compound preparation composed of two Chinese herbs, Bge....
8.
Chen M, Liu J, Cai B, Li J, Wu N, Guo X
Zootaxa
. 2021 Jun;
4974(1):116134.
PMID: 34186867
An adult sand snake specimen was collected during a herpetofaunal survey conducted in the Turpan Basin in northwest China. Phylogenetic analyses revealed that this specimen, along with other snake sloughs...
9.
Ling Y, Jin L, Ma Q, Huang Y, Yang Q, Chen M, et al.
Phytomedicine
. 2021 May;
87:153569.
PMID: 33985878
Background: Toll-like receptor 2 and Toll-like receptor 4 (TLR2/4) on microglia have been found as important regulators in the inflammatory response during cerebral ischemia/reperfusion (I/R). In China, traditional Chinese medicine...
10.
Zhu Y, Zhang Y, Li X, Su Y, Wang N, Chen M, et al.
Mol Med Rep
. 2021 Apr;
23(6).
PMID: 33899115
Esophageal cancer (EC) is one of the most malignant and lethal digestive‑related tumors worldwide. However, acquired drug resistance is a major obstacle concerning anticancer chemotherapy. An increasing number of studies...